Professor Stavroula Sofou received a 2-year, $50,000 Busch Biomedical Research Grant from the Charles and Johanna Busch Memorial Fund. The funds will support a research project entitled "Antivascular alpha-particle therapy by targeted liposomes loaded with Actinium-225".